Phenominer Database Results (12 results)

 

Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and vehicle control condition (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 32 2.84 null 0.31 1.75 manual palpation method 0.0 0 76264 1558
COP/OlaHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 212 and 330 days) Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 mammary gland integrity trait female 271 days-397 days 20 0.4 null 0.13 0.6 manual palpation method 0 0 11753 144
SPRD.WKY-(D18Wox8-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 46 7.61 null 0.45 3.05 manual palpation method 0 DMBA oral gavage 133 days 11356 74
BN/SsNHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 196 and 199 days) Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 mammary gland integrity trait female 259 days 13 0.0 null manual palpation method crystalline implant 0 11381 81
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and bisphenol A (250 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 24 5.0 null 0.88 4.31 manual palpation method 0.0 0 76266 1558
SPRD/Ztm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 17 10.89 null 0.43 1.77 manual palpation method 0 DMBA oral gavage 133 days 11354 74
SPRD.WKY-(D5Rat190-D5Rat114)(D18Rat102-D18Rat44)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 33 5.0 null 0.44 2.53 manual palpation method 0 DMBA oral gavage 133 days 11358 74
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 193 and 199 days) Schaffer BS, et al., Cancer Res. 2006 Aug 1;66(15):7793-800 mammary gland integrity trait female 143 days-259 days 22 8.8 null 1.4 6.57 manual palpation method 0.0 crystalline implant 0 11382 81
SPRD.WKY-(D5Rat190-D5Rat114)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 14 3.93 null 0.64 2.39 manual palpation method 0 DMBA oral gavage 133 days 11355 74
Crl:CD(SD) mammary tumor number maternal milk (for 20 days) and bisphenol A (25 ug/kg) (for 15 days) then 7,12-dimethyltetraphene (DMBA) (30 mg/kg) (for 1 days) Jenkins S, et al., Environ Health Perspect. 2009 Jun;117(6):910-5. doi: 10.1289/ehp.11751. Epub 2009 Jan 7. mammary gland integrity trait female 0 days-365 days 34 3.82 null 0.43 2.51 manual palpation method 0.0 0 76265 1558
ACI/SegHsd mammary tumor number 17 beta-estradiol (27.5 mg) (between 144 and 195 days) Shull JD, et al., Endocrinology 2001 Dec;142(12):5124-30 mammary gland integrity trait female 203 days-264 days 34 3.9 null 0.6 3.5 manual palpation method 0 0 11752 144
SPRD.WKY-(D10Rat91-D10Rat135)/Ibmm mammary tumor number 7,12-dimethyltetraphene (DMBA) (65 mg/kg) (for 133 days) Piessevaux G, et al., Mamm Genome. 2008 Dec 4 mammary gland integrity trait female 0 days 25 9.24 null 0.65 3.25 manual palpation method 0 DMBA oral gavage 133 days 11357 74